Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Antimicrob Chemother ; 67(8): 1811-8, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22577103

RESUMEN

OBJECTIVES: This study investigated the prevalence of vancomycin-resistant enterococci (VRE) in the broiler production environment after the avoparcin ban and their epidemiological relationship with human clinical VRE from the same geographical regions in Greece. METHODS: Caecal contents from broilers (n = 500) from eight livestock farms and faecal samples from poultry slaughterers (n = 50), all collected in two slaughterhouses during 2005-08, were analysed for species and vancomycin resistance gene identification using multiplex PCR. Sixty-three human clinical vancomycin-resistant Enterococcus faecium (VREF) isolates, obtained during 2006-09, were also examined. Discriminant analysis (DA) was used to establish the relationship of antimicrobial resistance profiles (ARPs) among broiler, poultry slaughterer and human clinical VREF. PFGE was conducted to study the genetic relatedness among VREF from the different sources. RESULTS: A total of 120 VRE were recovered from 113 (22.6%) broiler samples. VREF carrying the vanA gene were predominant, being recovered from 72 (14.4%) samples from five (62.5%) broiler farms. Concerning poultry slaughterers, VREF were recovered from 10 (20%) samples. Susceptibility testing revealed that broiler VREF were consistently resistant to tetracycline, whereas 93.7% of clinical VREF were resistant to ampicillin. Furthermore, 92.1% of clinical VREF compared with 54.4% of broiler VREF were multiresistant (resistant to at least five antimicrobial classes). DA classified broiler and human clinical VREF into their corresponding source with high classification rates (100% and 85.7%, respectively), while the classification rate of poultry slaughterer VREF was relatively low (50%), with 40% of them classified closely to broiler VREF. PFGE patterns were clearly related to the source of the VREF, with broiler isolates being clustered distinctly from all human isolates. CONCLUSIONS: A remarkable persistence of VREF was observed in the broiler production environment even >10 years after the avoparcin ban. Human and broiler VREF belonged to clearly unrelated populations, strongly indicating no clonal spread of VREF among the different sources, even between broilers and poultry slaughterers, despite them sharing common ARPs, as also supported by DA.


Asunto(s)
Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/genética , Portador Sano/microbiología , Enterococcus faecium/genética , Infecciones por Bacterias Grampositivas/microbiología , Carne/microbiología , Aves de Corral/microbiología , Adulto , Animales , Ciego/microbiología , Análisis por Conglomerados , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Enterococcus faecium/aislamiento & purificación , Infecciones por Bacterias Grampositivas/epidemiología , Grecia/epidemiología , Hospitalización , Humanos , Recién Nacido , Epidemiología Molecular , Tipificación Molecular , Resistencia a la Vancomicina
3.
Reprod Domest Anim ; 38(3): 187-92, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12753551

RESUMEN

The objective of this study was to assess the effects of in-feed chlortetracycline (CTC) as a measure of preventing or minimizing infectious problems of reproductive failure in gilts and sows. In a farm of 400 Large White x Landrace gilts and sows with a clinical history of porcine respiratory and reproductive syndrome (PRRS) virus, the animals were treated with CTC. Treatment consisted of 10 g CTC sow/day for 15 days every 3 months. It improved the health status of sows by decreasing post-farrowing clinical mastitis and vaginal discharges, abortions, return-to-oestrus and irregular return-to-oestrus rates. These beneficial effects had a positive impact on the performance of the litter. More piglets were born live and weaned. These positive effects improved with repeated use of CTC. The serological evidence of PRRS virus, Leptospira spp. and Chlamydia spp. and the subsequent beneficial use of the antimicrobial agent indicate that reproductive failure, possibly resulting from the bacterial agents can be controlled with in-feed use of broad spectrum antimicrobials.


Asunto(s)
Aborto Veterinario/prevención & control , Antibacterianos/uso terapéutico , Clortetraciclina/uso terapéutico , Suplementos Dietéticos , Síndrome Respiratorio y de la Reproducción Porcina , Reproducción/efectos de los fármacos , Aborto Veterinario/complicaciones , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Anticuerpos Antivirales/inmunología , Clortetraciclina/administración & dosificación , Clortetraciclina/farmacología , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Tamaño de la Camada , Virus del Síndrome Respiratorio y Reproductivo Porcino/inmunología , Virus del Síndrome Respiratorio y Reproductivo Porcino/aislamiento & purificación , Embarazo , Porcinos
4.
Artículo en Inglés | MEDLINE | ID: mdl-12420865

RESUMEN

The aim of this trial was to evaluate the effect of in-feed doxycycline (DOXY) on the control of ileitis in weaned piglets. On a farm with a previous history of ileitis outbreaks, 288 piglets at the age of weaning (25 +/- 2 days old) were divided into four experimental groups, each group comprising three pens with 24 piglets in each pen. Non-medicated animals served as negative control (NC) group, whereas groups DOXY-50, DOXY-125 and DOXY-250 received doxycycline via feed at 50, 125 and 250 ppm, respectively. Therapy lasted for 14 days followed by an observation period of 28 days. In conclusion, administration of doxycycline at a dose rate of 125 or 250 ppm had beneficial effect compared with the NC group. in terms of the reduction of diarrhoea prevalence, the enhancement of growth performance and the reduction of prevalence of Lawsonia intracellularis in the intestine, as shown either by the PCR method or by specific histopathological examinations. Treatment with 250 ppm of doxycycline for a fortnight interval post-weaning seems to be beneficial leading to better growth rates of piglets not only during treatment period, but also throughout the whole nursery phase.


Asunto(s)
Antibacterianos/uso terapéutico , Doxiciclina/uso terapéutico , Infecciones por Bacterias Gramnegativas/veterinaria , Ileítis/veterinaria , Enfermedades de los Porcinos/prevención & control , Alimentación Animal , Animales , Animales Recién Nacidos , Antibacterianos/administración & dosificación , ADN Bacteriano/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Doxiciclina/administración & dosificación , Esquema de Medicación , Femenino , Infecciones por Bacterias Gramnegativas/prevención & control , Ileítis/prevención & control , Lawsonia (Bacteria)/aislamiento & purificación , Masculino , Reacción en Cadena de la Polimerasa/veterinaria , Porcinos , Enfermedades de los Porcinos/microbiología , Resultado del Tratamiento , Destete
5.
Vet Microbiol ; 82(1): 39-43, 2001 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-11423193

RESUMEN

Clostridium perfringens isolated from lambs with dysentery (n=117) were analysed by a DNA amplification technique, the polymerase chain reaction (PCR), in order to determine the prevalence of the alpha-, beta-, beta 2-, epsilon-, iota- and enterotoxin genes. The most prevalent toxin type of C. perfringens found was type B, containing the alpha-, beta-, and epsilon-toxin genes, representing 46% of the cases with clostridial dysentery. C. perfringens type C containing the alpha-, and beta-toxin genes was isolated in 20% and type D, which is characterized by the alpha- and epsilon-toxin genes, was isolated in 28% of all isolates. The recently discovered, not yet assigned beta 2-toxigenic type of C. perfringens was represented in 6% of all isolates. No C. perfringens type A containing the alpha-toxin alone and no type E, which harbours the ADP-ribosylating iota-toxin, were found in the diseased animals. None of the samples contained the enterotoxin gene. Only one type of C. perfringens was found in a given herd, revealing the epidemiological use of PCR toxin gene typing of C. perfringens. The animals originated from 79 different herds with sizes ranging from 30 to 250 animals, bred in the area of northern Greece.


Asunto(s)
Infecciones por Clostridium/veterinaria , Clostridium perfringens/aislamiento & purificación , Disentería/veterinaria , Enterotoxinas/genética , Enfermedades de las Ovejas/microbiología , Animales , Infecciones por Clostridium/microbiología , Clostridium perfringens/genética , ADN Bacteriano/química , Disentería/microbiología , Femenino , Genotipo , Grecia , Masculino , Reacción en Cadena de la Polimerasa/veterinaria , Ovinos
6.
Zentralbl Veterinarmed B ; 45(2): 115-27, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9557133

RESUMEN

The aim of this study was to evaluate the effect of different antibiotics used as growth promoters on the control of porcine intestinal adenomatosis when administered in weaning, growing and fattening pig diets, according to Annex I of the European Union directive (70/524/EEC and its subsequent amendments to date) for the use of feed additives. On a farm with a previous history of proliferative enteropathy outbreaks, 648 weaned piglets (23 days old) were divided into nine experimental groups according to bodyweight and sex ratio, each group comprising four pens with 18 pigs in each pen. One group served the trial as a negative (unmedicated) control: another (the positive control) received monensin via feed at 100 p.p.m. up to the end of the growing phase (107 days old) and 50 p.p.m. up to slaughter age (156 days old). The remaining seven groups were offered feed with the addition of the following antibiotics: virginia-mycin (50-20 p.p.m.), avilamycin (40-20 p.p.m.), spiramycin (50-20 p.p.m.), zinc bacitracin (50-10 p.p.m.), avoparcin (40-20 p.p.m.), tylosin (40-20 p.p.m.) and salinomycin (60-30 p.p.m.), respectively. The performance of the pigs in the positive control group was very satisfying and among the highest in the trial, verifying earlier field studies. As a general conclusion it seems that all tested growth promoters had a beneficial effect compared with the untreated control, indicated by the decrease of mortality rate, the elimination of diarrhoeal incidence and the enhancement of growth performance, although the proliferative enteropathy control achieved by each substance was not always satisfactory. More specifically, the antibiotic growth promoters tested can be scaled according to their total efficacy as follows: 1. Salinomycin, tylosin, spiramycin; 2. Virginiamycin, zinc bacitracin, avilamycin; and 3. Avoparcin. Finally, it is considered that part of the growth promotion efficacy of the tested substances is due to their potential capacity to control porcine intestinal adenomatosis; thus, in future growth performance trials, the disease background of the trial farms must be examined, especially for porcine enteropathy challenges.


Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica/veterinaria , Infecciones Bacterianas/veterinaria , Sustancias de Crecimiento/uso terapéutico , Ileítis/veterinaria , Enfermedades de los Porcinos , Porcinos/crecimiento & desarrollo , Mataderos , Animales , Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Bacitracina/uso terapéutico , Infecciones Bacterianas/prevención & control , Brotes de Enfermedades/veterinaria , Femenino , Alimentos Fortificados , Glicopéptidos , Grecia/epidemiología , Sustancias de Crecimiento/administración & dosificación , Ileítis/epidemiología , Ileítis/fisiopatología , Ileítis/prevención & control , Íleon , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Monensina/administración & dosificación , Monensina/uso terapéutico , Oligosacáridos/administración & dosificación , Oligosacáridos/uso terapéutico , Piranos/administración & dosificación , Piranos/uso terapéutico , Espiramicina/administración & dosificación , Espiramicina/uso terapéutico , Enfermedades de los Porcinos/epidemiología , Tilosina/administración & dosificación , Tilosina/uso terapéutico , Virginiamicina/administración & dosificación , Virginiamicina/uso terapéutico
7.
Vet Rec ; 138(20): 489-92, 1996 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-8736501

RESUMEN

This field trial was designed to investigate whether the incorporation of zinc bacitracin into pig feed would prevent porcine intestinal adenomatosis. Two hundred-and-eighty-eight weaned pigs on a farm with a previous history of the disease were divided into 16 pens of 18 pigs. Two dietary regimens of zinc bacitracin were tested: from weaning up to 100 days of age, either 300 or 200 ppm zinc bacitracin were incorporated; from 100 to 125 days of age, either 200 or 100 ppm zinc bacitracin were added; and from 125 to 156 days of age (slaughter), either 100 or 50 ppm zinc bacitracin were added. The results were compared with a positive control group which received 60, 60 and 30 ppm salinomycin during the same periods, and with a negative control group which received no antibacterial and/or performance enhancer. The mortality, diarrhoea scores, average daily weight gains, average daily feed intakes and feed conversion ratios of the pigs were assessed. At slaughter, samples of ileum were taken from eight randomly selected pigs per group for bacteriological and histopathological examinations. The three treated groups all performed better than the control group, and the group receiving the high dose regimen of zinc bacitracin performed significantly better than the groups receiving the low dose of zinc bacitracin or salinomycin.


Asunto(s)
Poliposis Adenomatosa del Colon/veterinaria , Antibacterianos/uso terapéutico , Bacitracina/uso terapéutico , Neoplasias del Íleon/veterinaria , Enfermedades de los Porcinos/prevención & control , Poliposis Adenomatosa del Colon/tratamiento farmacológico , Poliposis Adenomatosa del Colon/prevención & control , Alimentación Animal , Animales , Antibacterianos/administración & dosificación , Bacitracina/administración & dosificación , Diarrea/prevención & control , Diarrea/veterinaria , Relación Dosis-Respuesta a Droga , Femenino , Neoplasias del Íleon/tratamiento farmacológico , Neoplasias del Íleon/prevención & control , Íleon/efectos de los fármacos , Íleon/patología , Masculino , Piranos/administración & dosificación , Piranos/uso terapéutico , Porcinos , Enfermedades de los Porcinos/tratamiento farmacológico , Enfermedades de los Porcinos/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA